Description
Tratamiento de episodios hemorrágicos en pacientes con hemofilia B
FABRICANTE: STREGER
Caja con 1 comprimido de 10 mg
PRINCIPIO ACTIVO: ACIDO IBANDRONICO
Puede utilizarse en pacientes con alto riesgo de formación de coágulos sanguíneos
ULFHINLAS 1 SUSP/AER 120 DOSIS 25MC/50MC VITAL CARE Tratamiento de episodios hemorrágicos en
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
